Qurient, Inc.
Major Drugs - N/A, N/A, kr
Qurient, Inc. Details
Qurient is a spin-off biotechnology company from institute Pasteur Korea (IPK) dedicated to develop novel therapeutics against infectious disease and inflammation. Qurient has exclusive right to use discovery research products (drug candidates) and resources at IPK including the PhenomicScreen. Simultaneously Qurient is searching for In-Licensing opportunities from external partners such as academia and biotech for aligned strategic indications.
Website:
qurient.com
Employees:
20 - 49
HQ:
N/A
Location:
N/A, N/A, kr
Revenue:
Not Available
Qurient, Inc. Technologies
Email Providers
Postini
Load Balancers
Apache
Tag Management
Google Tag Manager
Other
Mobile Friendly